GIGABYTE Debuts CAMM2 Memory on Z890 AORUS Tachyon ICE Motherboard

GIGABYTE shakes up memory for overclockers with CAMM2 DDR5 support on its latest Z890 AORUS Tachyon ICE motherboard, leaving DIMMs behind.

GIGABYTE has launched its updated Z890 AORUS Tachyon ICE motherboard, introducing support for CAMM2 DDR5 memory modules in place of traditional DIMMs. This new design is targeted at enthusiasts and overclockers, offering a considerable upgrade in both performance and ease of use. The board retains its hallmark 90-degree rotated CPU socket and top-mounted memory slots, but swaps multiple DIMM slots for a single CAMM2 connector, simplifying the memory installation process and optimizing cooling efficiency with a toolless heatsink that can be snapped on without tools.

The adoption of CAMM2 memory is expected to deliver notable improvements in memory signaling and attainable data rates. CAMM2 modules´ architecture inherently reduces signal interference compared to legacy DIMMs, supporting the pursuit of higher and more stable frequencies. GIGABYTE´s commitment to overclocking excellence is further highlighted by the recent world record set on the original Z890 AORUS Tachyon ICE, which achieved DDR5-12752 speeds courtesy of its in-house overclocking specialist, HiCookie, using V-Color´s Manta Xfinity RGB modules. This accomplishment demonstrates the platform´s capability and the potential unlocked by CAMM2.

As competitiveness in memory speeds intensifies, manufacturers continue to push the boundaries. G.Skill recently demonstrated a DDR5-10000 CAMM2 module, offering 64 GB capacity with dual-channel or quad sub-channel operation and timings of CL56-70-70. This development signals an industry shift towards higher density, faster, and more efficient memory solutions in the CAMM2 form factor, potentially setting the stage for further record-breaking achievements. For users focused on extreme memory performance, the GIGABYTE Z890 AORUS Tachyon ICE CAMM2 stands as a promising new platform embracing the future of motherboard memory technology.

62

Impact Score

HMS researchers design Artificial Intelligence tool to quicken drug discovery

Harvard Medical School researchers unveiled PDGrapher, an Artificial Intelligence tool that identifies gene target combinations to reverse disease states up to 25 times faster than current methods. The Nature-published study outlines a shift from single-target screening to multi-gene intervention design.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.